ArticleJournal of clinical hypertension (Greenwich, Conn.)2020
Renovascular hypertension from the BCR-ABL tyrosine kinase inhibitor ponatinib.
Syed O Amin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it